The Residual Risk Odyssey: From LDL to Lp(a)

Robert S. Rosenson, Sascha N. Goonewardena

Research output: Contribution to journalEditorial

8 Scopus citations
Original languageEnglish
Pages (from-to)434-436
Number of pages3
JournalJournal of the American College of Cardiology
Volume78
Issue number5
DOIs
StatePublished - 3 Aug 2021

Keywords

  • PCSK9 inhibitor
  • acute coronary syndrome
  • lipoprotein(a)
  • low-density lipoprotein cholesterol

Cite this